Partner Investment Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-17,247
| Closed | -$235K | – | 100 |
|
|
2019
Q1 | $235K | Buy |
+17,247
| New | +$235K | 0.27% | 63 |
|
|
2018
Q4 | – | Sell |
-15,886
| Closed | -$265K | – | 125 |
|
|
2018
Q3 | $265K | Sell |
15,886
-7,910
| -33% | -$132K | 0.2% | 86 |
|
|
2018
Q2 | $376K | Sell |
23,796
-5,983
| -20% | -$94.5K | 0.3% | 79 |
|
|
2018
Q1 | $378K | Buy |
+29,779
| New | +$378K | 0.41% | 62 |
|
|
2017
Q3 | – | Sell |
-15,296
| Closed | -$175K | – | 95 |
|
|
2017
Q2 | $175K | Sell |
15,296
-6,509
| -30% | -$74.5K | 0.24% | 74 |
|
|
2017
Q1 | $454K | Sell |
21,805
-41,766
| -66% | -$870K | 0.55% | 59 |
|
|
2016
Q4 | $1.32M | Buy |
63,571
+21,611
| +52% | +$449K | 1.75% | 17 |
|
|
2016
Q3 | $1.38M | Sell |
41,960
-33,042
| -44% | -$1.08M | 2.04% | 14 |
|
|
2016
Q2 | $1.87M | Buy |
75,002
+5,260
| +8% | +$131K | 3.06% | 3 |
|
|
2016
Q1 | $1.71M | Buy |
69,742
+32,986
| +90% | +$808K | 2.78% | 9 |
|
|
2015
Q4 | $1.21M | Buy |
36,756
+13,831
| +60% | +$457K | 1.99% | 18 |
|
|
2015
Q3 | $751K | Buy |
22,925
+4,792
| +26% | +$157K | 1.14% | 31 |
|
|
2015
Q2 | $961K | Buy |
18,133
+2,742
| +18% | +$145K | 1.35% | 29 |
|
|
2015
Q1 | $444K | Buy |
15,391
+7,969
| +107% | +$230K | 0.67% | 59 |
|
|
2014
Q4 | $216K | Sell |
7,422
-16,238
| -69% | -$473K | 0.09% | 75 |
|
|
2014
Q3 | $300K | Sell |
23,660
-4,233
| -15% | -$53.7K | 0.11% | 48 |
|
|
2014
Q2 | $560K | Buy |
+27,893
| New | +$560K | 0.11% | 56 |
|